Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Being overweight or obese is associated with more than 200 diseases, including cardiovascular disease, type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnoea, certain cancers, and metabolic dysfunction-associated steatotic liver disease (MASLD) [9]
Fatigue, reduced exercise tolerance, foggy thinking, and occasional tingling in the hands or feet
It's important to remember, however, that these benefits arise when GLP-1s are used under medical supervision as part of a comprehensive plan tailored to your individual needs
Weight Loss: In phase III trials, weight loss with the use of exenatide averaged between 0.9 and 2.8 kg over a 30-month time frame, with more weight loss associated when exenatide is added to existing metformin therapy
US$ 26.16
US$ 22.37
US$ 22.45
US$ 25.70
US$ 25.48
US$ 23.15
US$ 20.63
US$ 25.52
US$ 22.70
US$ 22.08
